PRL and schizophrenia: Negligible effects were seen with respect to changes in fasting glucose, total cholesterol, low-density lipoprotein cholesterol, prolactin elevation, and triglycerides' levels, at least in contrast with alternative SGAs and/or higher average dose regimens used for schizophrenia patients [87].